FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131892871> ?p ?o ?g. }

• W2131892871 endingPage "856" @default.
• W2131892871 startingPage "849" @default.
• W2131892871 abstract "Cationic liposomes containing the human interferon beta (HuIFNbeta) gene (IAB-1) was used for the clinical trial for glioma patients. HuIFNbeta gene therapy showed much higher anti-tumor activity compared with the administration of HuIFNbeta protein for melanoma. These results suggest that HuIFNbeta gene therapy is an attractive strategy for the treatment of melanoma.Stage IV or III melanoma patients with cutaneous or subcutaneous metastatic lesions were enrolled in this pilot study. IAB-1 was dissolved by sterile PBS at a concentration of 30 microg DNA/ml and was injected into cutaneous or subcutaneous metastatic nodules three times a week for 2 weeks and the effect on the injected and non-injected metastatic lesions was evaluated.Clinical responses were as follows (five patients): mixed response (MR) and no change in each one patient, and progressive disease in three patients. In the MR patient, the IAB-1 injected lesion disappeared clinically and histopathologically and one-half of IAB-1 non-injected skin metastases were transiently inflamed and mostly regressed. In the responded non-injected lesions of this patient, histopathologically, infiltration of CD4 positive T cells was observed around the melanoma cells in the dermis, which expressed the HLA-Class II antigen. Adverse events due to this gene therapy were not recognized in any of the patients.The efficacy of this gene therapy was generally insufficient; however, some immunological responses were recognized in one patient. No adverse events were observed. HuIFNbeta gene therapy could be an attractive strategy for treatment of a variety of malignancies, including melanoma, though some modifications should be required." @default.
• W2131892871 created "2016-06-24" @default.
• W2131892871 creator A5006138375 @default.
• W2131892871 creator A5015378186 @default.
• W2131892871 creator A5020193578 @default.
• W2131892871 creator A5023994936 @default.
• W2131892871 creator A5033702969 @default.
• W2131892871 creator A5033764996 @default.
• W2131892871 creator A5033780317 @default.
• W2131892871 creator A5041454354 @default.
• W2131892871 creator A5042799216 @default.
• W2131892871 creator A5052631483 @default.
• W2131892871 creator A5055290282 @default.
• W2131892871 creator A5064652216 @default.
• W2131892871 creator A5080473703 @default.
• W2131892871 creator A5083641551 @default.
• W2131892871 date "2008-10-19" @default.
• W2131892871 modified "2023-10-14" @default.
• W2131892871 title "A Pilot Study of Human Interferon Gene Therapy for Patients with Advanced Melanoma by in vivo Transduction Using Cationic Liposomes" @default.
• W2131892871 cites W1595716544 @default.
• W2131892871 cites W1966954049 @default.
• W2131892871 cites W1980566787 @default.
• W2131892871 cites W1982768448 @default.
• W2131892871 cites W1986801129 @default.
• W2131892871 cites W2002593980 @default.
• W2131892871 cites W2009642273 @default.
• W2131892871 cites W2010080741 @default.
• W2131892871 cites W2011914197 @default.
• W2131892871 cites W2052212954 @default.
• W2131892871 cites W2066437073 @default.
• W2131892871 cites W2084749107 @default.
• W2131892871 cites W2086400790 @default.
• W2131892871 cites W2090737037 @default.
• W2131892871 cites W2139248078 @default.
• W2131892871 cites W2158350288 @default.
• W2131892871 cites W2288605382 @default.
• W2131892871 cites W2329994491 @default.
• W2131892871 cites W2334782320 @default.
• W2131892871 doi "https://doi.org/10.1093/jjco/hyn114" @default.
• W2131892871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18945721" @default.
• W2131892871 hasPublicationYear "2008" @default.
• W2131892871 type Work @default.
• W2131892871 sameAs 2131892871 @default.
• W2131892871 citedByCount "21" @default.
• W2131892871 countsByYear W21318928712012 @default.
• W2131892871 countsByYear W21318928712013 @default.
• W2131892871 countsByYear W21318928712014 @default.
• W2131892871 countsByYear W21318928712016 @default.
• W2131892871 countsByYear W21318928712017 @default.
• W2131892871 countsByYear W21318928712018 @default.
• W2131892871 countsByYear W21318928712020 @default.
• W2131892871 countsByYear W21318928712021 @default.
• W2131892871 countsByYear W21318928712022 @default.
• W2131892871 crossrefType "journal-article" @default.
• W2131892871 hasAuthorship W2131892871A5006138375 @default.
• W2131892871 hasAuthorship W2131892871A5015378186 @default.
• W2131892871 hasAuthorship W2131892871A5020193578 @default.
• W2131892871 hasAuthorship W2131892871A5023994936 @default.
• W2131892871 hasAuthorship W2131892871A5033702969 @default.
• W2131892871 hasAuthorship W2131892871A5033764996 @default.
• W2131892871 hasAuthorship W2131892871A5033780317 @default.
• W2131892871 hasAuthorship W2131892871A5041454354 @default.
• W2131892871 hasAuthorship W2131892871A5042799216 @default.
• W2131892871 hasAuthorship W2131892871A5052631483 @default.
• W2131892871 hasAuthorship W2131892871A5055290282 @default.
• W2131892871 hasAuthorship W2131892871A5064652216 @default.
• W2131892871 hasAuthorship W2131892871A5080473703 @default.
• W2131892871 hasAuthorship W2131892871A5083641551 @default.
• W2131892871 hasBestOaLocation W21318928711 @default.
• W2131892871 hasConcept C104317684 @default.
• W2131892871 hasConcept C111599444 @default.
• W2131892871 hasConcept C121608353 @default.
• W2131892871 hasConcept C126322002 @default.
• W2131892871 hasConcept C142724271 @default.
• W2131892871 hasConcept C150903083 @default.
• W2131892871 hasConcept C155887181 @default.
• W2131892871 hasConcept C185592680 @default.
• W2131892871 hasConcept C197934379 @default.
• W2131892871 hasConcept C203014093 @default.
• W2131892871 hasConcept C207001950 @default.
• W2131892871 hasConcept C2776178377 @default.
• W2131892871 hasConcept C2777624698 @default.
• W2131892871 hasConcept C2777658100 @default.
• W2131892871 hasConcept C2777701055 @default.
• W2131892871 hasConcept C2781228144 @default.
• W2131892871 hasConcept C2909179924 @default.
• W2131892871 hasConcept C502942594 @default.
• W2131892871 hasConcept C55493867 @default.
• W2131892871 hasConcept C71924100 @default.
• W2131892871 hasConcept C86803240 @default.
• W2131892871 hasConceptScore W2131892871C104317684 @default.
• W2131892871 hasConceptScore W2131892871C111599444 @default.
• W2131892871 hasConceptScore W2131892871C121608353 @default.
• W2131892871 hasConceptScore W2131892871C126322002 @default.
• W2131892871 hasConceptScore W2131892871C142724271 @default.
• W2131892871 hasConceptScore W2131892871C150903083 @default.
• W2131892871 hasConceptScore W2131892871C155887181 @default.
• W2131892871 hasConceptScore W2131892871C185592680 @default.

• next